| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $9,824,848 | 7 | 100 |
| Autor Deborah M. | director | 0 | $0 | 1 | $450,558 | $-450,558 |
| Nark Ted C | director | 0 | $0 | 1 | $586,000 | $-586,000 |
| Kiely John | director | 0 | $0 | 1 | $882,000 | $-882,000 |
| Daly Jason B. | EVP, Chief Legal Officer | 0 | $0 | 2 | $3.77M | $-3.77M |
| Shah Nikita | Executive Vice President | 0 | $0 | 2 | $4.14M | $-4.14M |
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a …
Over the last 12 months, insiders at Amneal Pharmaceuticals, Inc. have bought $0 and sold $9.82M worth of Amneal Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Amneal Pharmaceuticals, Inc. have bought $1.46M and sold $16.37M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $210,500 was made by Patel Gautam (director) on 2021‑12‑17.
| 2026-08-13 | Sale | Kiely John | director | 50,000 0.016% | $17.64 | $882,000 | +11.93% | |
| 2026-08-12 | Sale | Shah Nikita | Executive Vice President | 146,403 0.0455% | $17.51 | $2.56M | +9.23% | |
| 2026-08-12 | Sale | Daly Jason B. | EVP, Chief Legal Officer | 210,000 0.0648% | $17.40 | $3.65M | +9.23% | |
| 2026-08-11 | Sale | Daly Jason B. | EVP, Chief Legal Officer | 6,613 0.0021% | $17.70 | $117,050 | +12.57% | |
| 2026-05-11 | Sale | Autor Deborah M. | director | 34,819 0.0111% | $12.94 | $450,558 | +39.75% | |
| 2025-11-17 | Sale | Nark Ted C | director | 50,000 0.0161% | $11.72 | $586,000 | +22.54% | |
| 2025-11-12 | Sale | Shah Nikita | Executive Vice President | 131,856 0.044% | $11.92 | $1.57M | +17.90% | |
| 2025-08-27 | Sale | Kiely John | director | 32,000 0.01% | $9.23 | $295,360 | +37.07% | |
| 2025-08-25 | Sale | Shah Nikita | Executive Vice President | 6,340 0.002% | $9.50 | $60,230 | +38.15% | |
| 2025-08-22 | Sale | Shah Nikita | Executive Vice President | 114,492 0.0367% | $9.66 | $1.11M | +33.47% | |
| 2025-08-20 | Sale | BOYER ANDREW S | Executive Vice President | 279,244 0.0887% | $9.38 | $2.62M | +35.92% | |
| 2025-08-15 | Sale | Konidaris Tasos | Executive Vice President & CFO | 219,159 0.0696% | $9.43 | $2.07M | +34.66% | |
| 2025-08-14 | Sale | Konidaris Tasos | Executive Vice President & CFO | 119,206 0.0376% | $9.30 | $1.11M | +35.36% | |
| 2025-08-14 | Sale | Shah Nikita | Executive Vice President | 71,694 0.0226% | $9.29 | $666,037 | +35.36% | |
| 2025-08-13 | Sale | Konidaris Tasos | Executive Vice President & CFO | 161,365 0.0504% | $9.22 | $1.49M | +35.21% | |
| 2025-08-12 | Sale | Shah Nikita | Executive Vice President | 50,000 0.0163% | $9.04 | $452,000 | +40.91% | |
| 2025-08-12 | Sale | BOYER ANDREW S | Executive Vice President | 33,436 0.0109% | $9.05 | $302,596 | +40.91% | |
| 2025-08-12 | Sale | Daly Jason B. | EVP, Chief Legal Officer | 22,000 0.0072% | $9.05 | $199,100 | +40.91% | |
| 2025-06-16 | Sale | Patel Gautam | director | 94,906 0.0202% | $8.02 | $761,146 | +48.83% | |
| 2025-06-10 | Sale | Patel Gautam | director | 56,426 0.0132% | $8.02 | $452,537 | +53.01% |
| Nark Ted C | director | 291029 0.0836% | $5.88M | 1 | 1 | +68.75% |
| Kiely John | director | 210252 0.0604% | $4.25M | 1 | 4 | +5.19% |
| Patel Gautam | director | 1609144 0.462% | $32.52M | 3 | 9 | +0.6% |
| Patel Chintu | Co-CEO | 512566 0.1472% | $10.36M | 6 | 0 | +5.05% |
| Patel Chirag K. | President & Co-CEO | 512566 0.1472% | $10.36M | 6 | 0 | +5.05% |
| MEISTER PAUL M | director | 353649 0.1015% | $7.15M | 2 | 0 | +58.69% |
| Fosun International Ltd | 10 percent owner | 327000 0.0939% | $6.61M | 2 | 0 | +21.64% |
| Todisco Joseph | Executive Vice President | 281319 0.0808% | $5.69M | 2 | 2 | <0.0001% |
| BOYER ANDREW S | Executive Vice President | 152426 0.0438% | $3.08M | 2 | 6 | <0.0001% |
| Bhadauria Pradeep | SVP, Chief Scientific Officer | 37500 0.0108% | $757,875.00 | 2 | 0 | <0.0001% |
| George Jeffrey P. | director | 23810 0.0068% | $481,200.10 | 1 | 0 | +15.29% |
| BISARO PAUL | Executive Chairman | 17000 0.0049% | $343,570.00 | 1 | 0 | <0.0001% |
| Stewart Robert A | President and CEO | 17000 0.0049% | $343,570.00 | 1 | 0 | <0.0001% |
$1,279,728,023 | 131 | 10.76% | $3.05B | |
$25,613,591 | 65 | -3.30% | $12.27B | |
$14,599,168 | 59 | 12.79% | $1.66B | |
$102,709,455 | 46 | 30.55% | $1.45B | |
$73,762,556 | 45 | -9.99% | $2.17B |
| Increased Positions | 160 | +64% | 17M | +11.08% |
| Decreased Positions | 105 | -42% | 13M | -8.48% |
| New Positions | 58 | New | 4M | New |
| Sold Out Positions | 28 | Sold Out | 2M | Sold Out |
| Total Postitions | 305 | +22% | 155M | +2.59% |
| Vanguard Group Inc | $227,310.00 | 5.72% | 17.95M | +403,582 | +2.3% | 2025-09-30 |
| Blackrock, Inc. | $178,172.00 | 4.48% | 14.07M | +2M | +16.01% | 2025-09-30 |
| Rubric Capital Management Lp | $156,160.00 | 3.93% | 12.33M | +624,609 | +5.33% | 2025-09-30 |
| Tpg Gp A, Llc | $156,082.00 | 3.93% | 12.33M | 0 | 0% | 2025-09-30 |
| Citadel Advisors Llc | $72,533.00 | 1.83% | 5.73M | +104,617 | +1.86% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $68,758.00 | 1.73% | 5.43M | +133,764 | +2.52% | 2025-09-30 |
| Nantahala Capital Management, Llc | $53,483.00 | 1.35% | 4.22M | -142,874 | -3.27% | 2025-09-30 |
| Geode Capital Management, Llc | $51,078.00 | 1.29% | 4.03M | +275,538 | +7.33% | 2025-09-30 |
| State Street Corp | $50,308.00 | 1.27% | 3.97M | +58,412 | +1.49% | 2025-09-30 |
| Neuberger Berman Group Llc | $47,046.00 | 1.18% | 3.72M | -7,253 | -0.2% | 2025-09-30 |